TECH · BIO-TECHNE Corp · Executive Compensation

$72.55 -0.07 (-0.10%) At close · Oct 23

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$11.38B

156.82M

Volume · Oct 23 1.9M Avg daily vol (3M) 3.03M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kim Kelderman	President and CEO	$936,000	—	$3,929,942	$1,932,848	$1,318,917	$33,473	$8,151,181
James T. Hippel	Executive Vice President and CFO	$723,000	—	$4,453,020	$907,273	$926,163	$17,926	$7,027,382
William Geist	President, Protein Sciences	$573,200	—	$1,206,585	$593,448	$748,026	$18,040	$3,139,299
Matthew McManus	President, Diagnostics and Spatial Biology	$572,000	—	$1,213,200	$596,695	$444,787	$19,937	$2,846,619
Shane Bohnen	Senior Vice President and General Counsel	$431,000	—	$767,575	$377,496	$386,478	$18,183	$1,980,732

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kim Kelderman	President and CEO Former President, Diagnostics and Genomics	$759,511	—	$1,935,433	$3,858,418	$285,394	$13,739	$6,852,495
Charles Kummeth	Former President and CEO	$1,184,200	—	$5,000,028	—	$596,837	$11,880	$6,792,945
Charles R. Kummeth	Former President and CEO	$1,184,200	—	$5,000,028	—	$596,837	$11,880	$6,792,945
James T. Hippel	Executive Vice President and CFO	$695,167	—	$2,112,272	$2,165,618	$218,978	$10,597	$5,202,632
William Geist	President, Protein Sciences	$551,200	—	$1,519,768	$1,417,508	$144,855	$13,887	$3,647,219
Matthew McManus	President, Diagnostics and Genomics	$253,846	—	$1,081,995	$527,793	$124,027	$6,980	$1,994,642
Shane Bohnen	Senior Vice President and General Counsel	$344,760	—	$262,517	$762,509	$76,020	$9,988	$1,455,793

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles R. Kummeth	Former President and CEO	$1,184,200	—	$5,000,108	$24,325,102	$54,092	$21,141	$30,584,644
Charles Kummeth	Former President and CEO	$1,184,200	—	$5,000,108	$24,325,102	$54,092	$21,141	$30,584,644
James T. Hippel	Executive Vice President and CFO	$668,430	—	$687,601	$2,062,485	$13,520	$9,834	$3,441,870
Kim Kelderman	President and CEO Former President, Diagnostics and Genomics	$589,890	—	$440,085	$1,319,921	$246,717	$9,099	$2,605,711
William Geist	President, Protein Sciences	$530,000	—	$449,915	$1,350,043	—	$3,669	$2,333,628
Brenda Furlow	Former Executive Vice President and General Counsel	$377,684	—	$750,111	$749,943	$6,268	$4,575	$1,888,581
Shane Bohnen	Senior Vice President and General Counsel	$331,500	—	$499,945	$190,699	$22,100	—	$1,044,244
Matthew McManus	President, Diagnostics and Genomics	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles Kummeth	Former President and CEO	$1,183,000	—	$5,149,692	$5,149,669	$3,856,735	$31,452	$15,370,549
Charles R. Kummeth	Former President and CEO	$1,183,000	—	$5,149,692	$5,149,669	$3,856,735	$31,452	$15,370,549
James T. Hippel	Executive Vice President and CFO	$636,600	—	$624,760	$1,874,812	$1,289,740	$10,117	$4,436,029
David Eansor	Former President, Protein Sciences	$448,141	—	$499,808	$1,499,825	$757,492	$4,140	$3,209,406
Brenda Furlow	Former Executive Vice President and General Counsel	$533,700	—	$374,856	$1,124,838	$915,560	$9,272	$2,958,226
Kim Kelderman	President and CEO Former President, Diagnostics and Genomics	$561,800	—	$399,911	$1,199,909	$776,445	$9,302	$2,947,367
William Geist	President, Protein Sciences	$239,600	—	$1,224,789	$674,897	$425,000	—	$2,564,286
Matthew McManus	President, Diagnostics and Genomics	—	—	—	—	—	—	—
Shane Bohnen	Senior Vice President and General Counsel	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles Kummeth	President and CEO	$1,116,000	—	$4,599,864	$6,599,940	$3,537,214	$36,879	$15,889,896
Charles R. Kummeth	President and CEO	$1,116,000	—	$4,599,864	$6,599,940	$3,537,214	$36,879	$15,889,896
David Eansor	Former President, Protein Sciences	$585,000	—	$459,844	$4,379,953	$1,005,360	$8,372	$6,438,528
Brenda Furlow	Former Executive Vice President and General Counsel	$503,500	—	$299,836	$2,899,923	$761,021	$8,396	$4,472,676
James T. Hippel	Executive Vice President and CFO	$600,500	—	$574,849	$2,724,928	$1,095,156	$9,445	$3,157,058
Kim Kelderman	President, Diagnostics and Genomics	$530,000	—	$359,839	$2,079,987	$908,102	$8,389	$2,175,311
Shane Bohnen	Senior Vice President and General Counsel	—	—	—	—	—	—	—
William Geist	President, Protein Sciences	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles Kummeth	President and CEO	$1,053,000	—	$4,310,652	$4,310,748	$1,767,957	$41,425	$11,484,782
Charles R. Kummeth	President and CEO	$1,053,000	—	$4,310,652	$4,310,748	$1,767,957	$41,425	$11,483,782
James T. Hippel	Executive Vice President and CFO	$566,000	—	$502,389	$1,502,483	$576,716	$9,470	$3,157,058
David Eansor	Former President, Protein Sciences	$552,000	—	$401,988	$1,201,974	$521,387	$8,400	$2,685,749
Kim Kelderman	President, Diagnostics and Genomics	$500,000	—	$301,459	$901,452	$464,000	$8,400	$2,175,311
Brenda Furlow	Executive Vice President and General Counsel	$475,000	—	$251,195	$751,223	$337,841	$8,400	$1,823,659
William Geist	President, Protein Sciences	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles Kummeth	President and CEO	$957,000	—	$3,999,925	$4,000,343	$2,008,183	$45,688	$11,011,138
James T. Hippel	Senior Vice President of Finance and CFO	$514,188	—	$399,916	$1,200,090	$634,254	$9,342	$2,757,790
David Eansor	President, Protein Sciences	$501,380	—	$299,907	$900,053	$613,448	$8,250	$2,323,038
Kim Kelderman	President, Diagnostics and Genomics	$452,400	—	$199,899	$600,028	$304,796	$8,250	$1,565,373
Brenda Furlow	Senior Vice President – General Counsel	$431,400	—	$162,425	$487,524	$350,574	$8,250	$1,483,773

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles Kummeth	President and CEO	$911,000	—	$3,550,008	$3,550,081	$1,610,925	$42,860	$9,664,874
James T. Hippel	Senior Vice President of Finance and CFO	$476,100	—	$370,000	$1,110,007	$483,485	$9,295	$2,448,887
David Eansor	President, Protein Sciences	$455,000	—	$181,248	$543,753	$403,181	$8,100	$1,591,282
Brenda Furlow	Senior Vice President – General Counsel	$385,000	—	$143,731	$431,239	$250,132	$8,100	$1,218,202

Executive changes

Person	Role	Change	Effective	Filed
Steve Crouse	President, Diagnostics and Spatial Biology Segment	Appointed	2026-03-01	2026-02-11
Amy Herr	independent director	Appointed	2025-02-01	2025-02-05
Dr. Judith Klimovsky	independent director	Appointed	2024-04-24	2024-04-30
Kim Kelderman	Chief Executive Officer	Appointed	2024-02-01	2024-01-08
Matthew F. McManus	President, Diagnostics and Genomics Segment	Appointed	2024-01-08	2024-01-08
Dr. Matthew McManus	President – Diagnostics and Genomics Segment	Appointed	2024-01-08	2024-01-08
Kim Kelderman	Director	Appointed	2024-02-01	2023-10-19
Kim Kelderman	Chief Executive Officer	Appointed	2024-02-01	2023-10-19
Kim Kelderman	Chief Operating Officer	Appointed	2023-11-01	2023-10-19
Brenda Furlow	Executive Vice President and General Counsel	Retired	2023-03-03	2023-01-31
Shane Bohnen	Senior Vice President, General Counsel and Corporate Secretary	Appointed	2023-03-03	2023-01-31
Chuck Kummeth	Chief Executive Officer	Retired	2024-06-30	2022-08-05

Leadership

Charles Kummeth CEO
James T. Hippel CFO
Kim Kelderman COO, Board Member
Shane Bohnen General Counsel
Alpna Seth Board Member
Amy Herr Board Member
Charles R. Kummeth Board Member
Dr. Amy Herr Board Member
Dr. Judith Klimovsky Board Member
John L. Higgins Board Member
Joseph D. Keegan Board Member
Julie L. Bushman Board Member
Randolph C. Steer Board Member
Robert V. Baumgartner Board Member
Roeland Nusse Board Member
Rupert Vessey Board Member

Key facts CIK 842023 CUSIP 09073M104 13F (30d) 99 filings 94 filers Visit website Investor relations